Menu
Not yet recruiting NCT07412964

The Effect of Pink Noise and the Quiet Night Intervention on Sleep Parameters in Intensive Care Unit Patients: A Single-Center Randomized Controlled Trial

No phase Interventional Sleep Disturbance Intensive Care Units

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Acoustic Noise Masking Intervention, Quiet Night Intervention.
Who it may be relevant to
Registry conditions: Sleep Disturbance, Intensive Care Units. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Turkey (Türkiye)
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

The Effect of Pink-Brown Noise and the Quiet Time Intervention on Sleep Parameters in Intensive Care Unit Patients: A Single-Center, Randomized Controlled Trial

Overview

Sleep disruption is common in adult intensive care unit (ICU) patients and is often worsened by environmental noise and nighttime care activities. Poor sleep may negatively affect recovery and well-being. This single-center, three-arm randomized controlled trial will evaluate the short-term effects of two non-pharmacological interventions-(1) pink-brown noise masking and (2) a quiet time intervention-on objective sleep parameters in adult ICU patients, compared with standard care. Sleep outcomes will be measured using actigraphy-based wearable monitoring, including total sleep time, sleep efficiency, sleep onset latency, wake after sleep onset, and number of awakenings. Results are expected to support evidence-based nursing approaches to improve sleep in ICU patients.

Detailed description

This study is designed as a single-center, three-arm, parallel-group randomized controlled clinical trial to evaluate the short-term effects of environmental acoustic masking and a quiet night intervention on objective sleep parameters in adult intensive care unit (ICU) patients.

Sleep disturbance is highly prevalent among critically ill patients due to environmental factors such as excessive noise, continuous light exposure, frequent nursing interventions, alarm sounds, mechanical ventilation, pain, anxiety, and disease-related physiological stress. These factors lead to fragmented and superficial sleep, disruption of the sleep-wake cycle, and are associated with adverse clinical outcomes including delirium, immune dysfunction, hemodynamic instability, prolonged ICU stay, and increased morbidity.

The study includes three groups:

1. an acoustic masking intervention group, 2. a quiet night intervention group, and 3. a standard care control group.

The acoustic masking group will receive low-frequency, nature-based sound exposure prior to sleep onset, followed by earplug use throughout the night. The quiet night group will receive environmental noise and light reduction measures supported by earplugs and an eye mask. The control group will receive standard ICU care without additional sleep-promoting interventions.

Objective sleep parameters will be measured using wrist-worn actigraphy over a single night (23:00-06:00). Primary sleep outcomes include total sleep time, sleep efficiency, sleep onset latency, wake after sleep onset, and number of nocturnal awakenings. Actigraphy is selected as a feasible, non-invasive, and validated method for sleep assessment in critically ill populations.

Prior to the main trial, a pilot phase will be conducted to assess the feasibility of the study procedures, the applicability of the interventions, the functionality of data collection methods, and the variability of outcome measures required for sample size estimation. The pilot phase will include all three study arms and will follow the same methodology, eligibility criteria, intervention protocols, and outcome assessments as the main trial. Participants enrolled in the pilot phase will constitute an independent sample and will not be included in the final analysis of the main trial.

Data obtained from the pilot phase will be used solely for methodological refinement and sample size calculation. Findings from the pilot phase may be disseminated separately.

The study aims to generate evidence for low-cost, non-invasive, nurse-led environmental interventions that can be integrated into routine ICU care to improve sleep quality in critically ill patients.

Interventions

  • Behavioral Acoustic Noise Masking Intervention
    Environmental acoustic noise masking applied before and during nighttime sleep to reduce ambient ICU noise and support sleep continuity.
  • Behavioral Quiet Night Intervention
    A quiet night protocol including environmental noise and light reduction supported by earplugs and an eye mask.

Primary outcome measures

  • Sleep Efficiency [Time frame: Single night (23:00-06:00)]
Secondary outcome measures (4)
  • Total Sleep Time [Time frame: Single night (23:00-06:00)]
  • Sleep Onset Latency [Time frame: Single night (23:00-06:00)]
  • Wake After Sleep Onset [Time frame: Single night (23:00-06:00)]
  • Number of Nocturnal Awakenings [Time frame: Single night (23:00-06:00)]

Eligibility criteria

Inclusion criteria

  • Inclusion Criteria:
  • Adults aged 18 years and older
  • Patients admitted to the adult intensive care unit
  • Expected ICU stay of at least one night
  • Ability to tolerate non-invasive sleep-related interventions (earplugs, eye mask, or acoustic masking)
  • Informed consent obtained from the patient or legally authorized representative

Exclusion criteria

Exclusion criteria

  • Severe hearing impairment preventing use of acoustic interventions
  • Severe cognitive impairment or coma preventing sleep assessment
  • Use of continuous deep sedation
  • Diagnosed sleep disorders requiring pharmacological treatment
  • Skin conditions preventing use of wrist-worn actigraphy

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Single blind
Primary purpose
Supportive care

Study locations

Turkey (Türkiye) · 1 center
  • Bolu Izzet Baysal State Hospital — Bolu

Identifiers

NCT: NCT07412964 · AIBU-SBF-NSS-2026

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗